Throughout this paper, a generic iteration algorithm for a finite family of total asymptotically quasi-nonexpansive maps in uniformly convex Banach space is suggested. As well as weak / strong convergence theorems of this algorithm to a common fixed point are established. Finally, illustrative numerical example by using Matlab is presented.

Let R be a commutative ring with identity and let M be a unital left Rmodule.
Goodearl introduced the following concept :A submodule A of an R –
module M is an y – closed submodule of M if is nonsingular.In this paper we
introduced an y – closed injective modules andchain condition on y – closed
submodules.

  Let L be a commutative ring with identity and let W be a unitary left L- module. A submodule D of an L- module W is called  s- closed submodule denoted by  D ≤sc W, if D has   no  proper s- essential extension in W, that is , whenever D ≤ W such that D ≤se H≤ W, then D = H. In  this  paper,  we study  modules which satisfies  the ascending chain  conditions (ACC) and descending chain conditions (DCC) on this kind of submodules.

Let  be a module over a commutative ring  with identity. Before studying the concept of the Strongly Pseudo Nearly Semi-2-Absorbing submodule, we need to mention the ideal  and the basics that you need to study the  concept of the Strongly Pseudo Nearly Semi-2-Absorbing submodule. Also, we introduce several characteristics of the Strongly Pseudo Nearly Semi-2-Absorbing submodule in classes of multiplication modules and other types of modules. We also had no luck because the ideal  is not a Strongly Pseudo Nearly Semi-2-Absorbing ideal. Also, it is noted that  is the Strongly Pseudo Nearly Semi-2-Absorbing ideal under several conditions, which is this faithful module, projective module, Z-regular module and content module and non-si

Ebastine (EBS) is a poorly water-soluble antihistaminic drug; it belongs to the class II group according to the biopharmaceutical classification system (BCS). The aim of the present work was to enhance the solubility, dissolution rate and micromeritic properties of the drug, by formulating it as spherical crystal agglomerates by Quasi Emulsion Solvent Diffusion (QESD) method.

Spherical crystal agglomerates (SCAs) were prepared in presence of three solvents dichloromethane (DCM), water and chloroform as a good solvent, poor solvent and bridging solvent respectively.  Agglomeration of EBS involved the use of some hydrophilic polymers like polyethylene glycol 4000 (PEG 4000), polyvinyl pyrrolidine K30 (PVP K30), D-?-tocopheryl